A tailored approach of vitamin D3 supplementation in patients who have suffered a heart attack significantly reduces their risk of a second heart attack, a new study from heart researchers at Intermountain Health in Salt Lake City…
Category: 6. Health
-
Stress hyperglycemia ratio and mortality in critically ill patients with heart failure: a retrospective cohort study from the MIMIC-IV database | BMC Cardiovascular Disorders
Savarese G, Becher PM, Lund LH, Seferovic P, Rosano GMC, Coats AJS. Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovasc Res. 2023;118:3272–87. https://doi.org/10.1093/cvr/cvac013.
Continue Reading
-
KP Health Department Issues Influenza Alert Amid Rising Cases
The Khyber Pakhtunkhwa (KP) Health Department has released a province-wide health advisory following an increase in influenza cases, warning that the virus may continue spreading until April next year. The move comes after fresh guidance from…
Continue Reading
-
Nirsevimab, Maternal Vaccine Show Effectiveness Against RSV – Medscape
- Nirsevimab, Maternal Vaccine Show Effectiveness Against RSV Medscape
- Nirsevimab prevents RSV cases in young kids for 1 year but maybe not beyond, data suggest CIDRAP
- RSV immunisation could prevent thousands of babies being hospitalised Evening…
Continue Reading
-
Expanding the waitlisting criteria for kidney transplantation could improve patient outcomes
The current kidney transplant waitlisting criterion is based on a single measurement of kidney function (estimated glomerular filtration rate [eGFR] ≤20 ml/min/1.73m2) and does not consider an individual’s risk of progressing to…
Continue Reading
-
Even a 15-minute walk may help boost your longevity – The Washington Post
- Even a 15-minute walk may help boost your longevity The Washington Post
- You don’t always need to do 8,000 to 10,000 steps a day anymore Lifestyle.INQ
- Short walks or long walks for your heart health? Researchers explore The Manual
- Exercise…
Continue Reading
-
AstraZeneca's $1.3B bet reduces blood pressure by 14 mmHg over 12 weeks in phase 3 win – Fierce Biotech
- AstraZeneca’s $1.3B bet reduces blood pressure by 14 mmHg over 12 weeks in phase 3 win Fierce Biotech
- Astrazeneca Says Hypertension Drug Meets Main, Secondary Goals in Phase 3 Study MarketScreener
- Baxdrostat demonstrated a statistically…
Continue Reading
-
Genetic and cellular mechanisms underlying steatotic liver disease
Steatotic liver disease (SLD), mainly encompassing metabolic dysfunction-associated steatotic liver disease (MASLD), alcohol-related liver disease (ALD), and metabolic dysfunction and ALD (MetALD), has emerged as the dominant…
Continue Reading
-
Antibody from Tanzanian woman suppresses almost all tested HIV variants including resistant viruses in pre-clinical study
An antibody from a Tanzanian woman discovered during screening for anti-HIV antibodies shows a strong therapeutic potential in a preclinical study. Named 04_A06, it neutralised (blocked) 97.3% of over 300 HIV strains tested, and blocked 77% of…
Continue Reading
-
Research cautions that ignoring calorie reductions on intermittent fasting reduces benefits
Without changing a person’s caloric intake, intermittent fasting does not lead to measurable metabolic or cardiovascular improvements, according to new research. The study focused on time-restricted eating (TRE), a form of intermittent fasting…
Continue Reading